As of Mar 27
| +1.21 / +4.66%|
The 6 analysts offering 12-month price forecasts for Celldex Therapeutics Inc have a median target of 36.50, with a high estimate of 45.00 and a low estimate of 32.00. The median estimate represents a +34.34% increase from the last price of 27.17.
The current consensus among 6 polled investment analysts is to Buy stock in Celldex Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.